Sun Pharma Shares Sink 10 Per Cent As Results Lag Estimates

Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares in Sun Pharma fell a huge 10 per cent after its Q4 numbers for the year ending March 31, 2015 disappointed the markets. Sun Pharma has been one of the top Sensex gainers in Narendra Modi's one year as Prime Minister as investors were hopeful that the merger with Ranbaxy would boost synergies and hence earnings.

    Sun Pharma Shares Sink 10 Per Cent As Results Lag Estimates
    Sun Pharmaceutical Industries: Quotes, News
    BSE 530.55BSE Quote10.95 (2.06%)
    NSE 531.55NSE Quote11.8 (2.22%)
    However, the consolidated net profits of Sun Pharma which came in at Rs 888.05 crore for the fourth quarter ended 31 March 2015 was a huge disappointment.
     

    The company had posted a net profit of Rs 1,587.12 crore for the same period of the previous fiscal. The stock was last trading at Rs 974 on the National Stock Exchange, down 9.5 per cent. Almost one week back the stock had closed above the Rs 1000 levels. Dealers say there maybe more downside risk to the stock given its huge out performance in the last one year.

    GoodReturns.in

    Read more about: sun pharma
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more